The downgrade is based on several factors, including MCHD’s significant concentration in mineral values resulting in assessed values that are estimated to fall between fiscal year 2015 and 2017.
The outlook is negative, reflecting Moody’s Investors Services expectation of a 22 percent decline in MCHD’s revenue due to the tax base contraction.
More articles on healthcare finance:
Baystate Health asks for $10M to save 200 jobs
Maine hospital to stop outpatient addiction services
Baker Tilly partner appointed to HFMA Principles and Practices Board: 3 things to know
